US Stock MarketDetailed Quotes

FDMT 4D Molecular Therapeutics

Watchlist

6.310
+0.530+9.17%

Close Dec 20 16:00 ET

6.310
0.0000.00%

Post 17:25 ET

291.70MMarket Cap-2.21P/E (TTM)

4D Molecular Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q3)Sep 30, 2024

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-2,409.91%-29.39M

-37.06%-30.24M

-4.24%-29.09M

12.57%-75.79M

-10.97%-24.65M

94.43%-1.17M

-10.86%-22.07M

-18.50%-27.91M

-25.39%-86.69M

-1.73%-22.21M

Net income from continuing operations

-327.49%-43.84M

-18.02%-34.95M

-12.97%-32.4M

6.19%-100.84M

-17.91%-32.28M

60.08%-10.26M

-5.45%-29.62M

-8.90%-28.68M

-50.73%-107.49M

-9.15%-27.38M

Operating gains losses

-79.89%36K

133.33%35K

-24.14%22K

188.24%245K

10.00%22K

1,276.92%179K

-34.78%15K

0.00%29K

-52.51%85K

5.26%20K

Depreciation and amortization

21.99%1.7M

13.73%1.62M

12.89%1.59M

48.17%5.75M

9.01%1.51M

58.82%1.4M

71.84%1.43M

80.56%1.41M

28.48%3.88M

80.26%1.39M

Change In working capital

173.18%8.46M

-150.63%-688K

21.62%-3.52M

147.16%630K

285.47%664K

417.09%3.1M

-46.43%1.36M

-76.95%-4.49M

91.40%-1.34M

82.03%-358K

-Change in receivables

----

--0

----

-96.73%47K

--0

-Change in prepaid assets

258.85%1.82M

-78.41%-1.01M

-1,568.89%-1.32M

-213.28%-1.4M

109.07%223K

-211.04%-1.15M

-134.39%-565K

-91.15%90K

129.23%1.24M

54.50%-2.46M

-Change in payables and accrued expense

52.46%7.6M

13.44%2.39M

54.80%-1.69M

403.78%4.27M

-72.75%909K

912.89%4.98M

139.75%2.11M

-35.44%-3.73M

-71.52%847K

51.84%3.34M

-Change in other current assets

-689.86%-545K

-1,507.27%-1.55M

20.00%-88K

-536.36%-70K

-100.23%-1K

---69K

--110K

---110K

---11K

--440K

-Change in other current liabilities

13.74%-408K

-909.80%-515K

-13.09%-501K

-348.46%-1.45M

-13.55%-486K

-6.05%-473K

-128.49%-51K

-219.41%-443K

67.60%-324K

-465.81%-428K

-Change in other working capital

98.47%-3K

97.92%-5K

125.84%77K

77.16%-715K

101.52%19K

60.80%-196K

-47.24%-240K

75.55%-298K

78.74%-3.13M

-454.55%-1.25M

Cash from discontinued investing activities

Operating cash flow

-2,409.91%-29.39M

-37.06%-30.24M

-4.24%-29.09M

12.57%-75.79M

-10.97%-24.65M

94.43%-1.17M

-10.86%-22.07M

-18.50%-27.91M

-25.39%-86.69M

-1.73%-22.21M

Investing cash flow

Cash flow from continuing investing activities

-8.94%27.3M

-249.20%-73.54M

-710.38%-263.26M

778.69%115.72M

81.32%-6.68M

95.05%29.98M

-14.23%49.29M

179.71%43.13M

90.13%-17.05M

-10.80%-35.78M

Net PPE purchase and sale

-339.01%-1.78M

56.65%-349K

29.84%-710K

75.98%-2.77M

49.77%-549K

79.38%-405K

61.04%-805K

84.22%-1.01M

-26.63%-11.54M

78.55%-1.09M

Net investment purchase and sale

-4.30%29.08M

-246.11%-73.19M

-694.78%-262.55M

2,248.86%118.49M

82.32%-6.13M

75.29%30.39M

-15.86%50.09M

192.55%44.14M

96.63%-5.51M

-27.55%-34.69M

Cash from discontinued investing activities

Investing cash flow

-8.94%27.3M

-249.20%-73.54M

-710.38%-263.26M

778.69%115.72M

81.32%-6.68M

95.05%29.98M

-14.23%49.29M

179.71%43.13M

90.13%-17.05M

-10.80%-35.78M

Financing cash flow

Cash flow from continuing financing activities

-94.62%568K

-86.78%17.25M

2,800.05%318.83M

4,983.70%156.83M

132.75%4.76M

2,195.00%10.56M

261,138.00%130.52M

1,647.85%10.99M

-97.39%3.09M

-98.24%2.05M

Net common stock issuance

-99.99%1K

-87.90%15.69M

3,172.72%315.72M

--148.34M

--1K

--8.98M

--129.72M

--9.65M

--0

Proceeds from stock option exercised by employees

-45.48%567K

22.50%1.56M

119.84%3.11M

138.90%8.49M

89.38%4.76M

940.00%1.04M

1,885.94%1.27M

61.83%1.42M

-6.33%3.55M

180.27%2.51M

Net other financing activities

----

-314.04%-472K

71.95%-69K

---468K

----

Cash from discontinued financing activities

Financing cash flow

-94.62%568K

-86.78%17.25M

2,800.05%318.83M

4,983.70%156.83M

132.75%4.76M

2,195.00%10.56M

261,138.00%130.52M

1,647.85%10.99M

-97.39%3.09M

-98.24%2.05M

Net cash flow

Beginning cash position

-19.99%189.06M

250.77%275.59M

375.84%249.11M

-65.78%52.35M

154.56%275.68M

108.23%236.31M

3.42%78.57M

-65.78%52.35M

-44.71%153M

19.02%108.3M

Current changes in cash

-103.87%-1.52M

-154.86%-86.53M

1.02%26.49M

295.49%196.76M

52.51%-26.57M

859.10%39.37M

320.49%157.74M

134.04%26.22M

18.65%-100.65M

-190.22%-55.95M

End cash Position

-31.97%187.54M

-19.99%189.06M

250.77%275.59M

375.84%249.11M

154.56%275.68M

108.23%236.31M

3.42%78.57M

-65.78%52.35M

Free cash flow

-1,877.73%-31.17M

-33.76%-30.59M

-3.04%-29.8M

20.01%-78.56M

-8.12%-25.2M

93.14%-1.58M

-4.10%-22.87M

3.49%-28.92M

-25.53%-98.22M

13.46%-23.31M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

Unqualified Opinion with Explanatory Notes

	(Q3)Sep 30, 2024	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-2,409.91%-29.39M	-37.06%-30.24M	-4.24%-29.09M	12.57%-75.79M	-10.97%-24.65M	94.43%-1.17M	-10.86%-22.07M	-18.50%-27.91M	-25.39%-86.69M	-1.73%-22.21M
Net income from continuing operations	-327.49%-43.84M	-18.02%-34.95M	-12.97%-32.4M	6.19%-100.84M	-17.91%-32.28M	60.08%-10.26M	-5.45%-29.62M	-8.90%-28.68M	-50.73%-107.49M	-9.15%-27.38M
Operating gains losses	-79.89%36K	133.33%35K	-24.14%22K	188.24%245K	10.00%22K	1,276.92%179K	-34.78%15K	0.00%29K	-52.51%85K	5.26%20K
Depreciation and amortization	21.99%1.7M	13.73%1.62M	12.89%1.59M	48.17%5.75M	9.01%1.51M	58.82%1.4M	71.84%1.43M	80.56%1.41M	28.48%3.88M	80.26%1.39M
Change In working capital	173.18%8.46M	-150.63%-688K	21.62%-3.52M	147.16%630K	285.47%664K	417.09%3.1M	-46.43%1.36M	-76.95%-4.49M	91.40%-1.34M	82.03%-358K
-Change in receivables	----	----	----	--0	----	----	----	----	-96.73%47K	--0
-Change in prepaid assets	258.85%1.82M	-78.41%-1.01M	-1,568.89%-1.32M	-213.28%-1.4M	109.07%223K	-211.04%-1.15M	-134.39%-565K	-91.15%90K	129.23%1.24M	54.50%-2.46M
-Change in payables and accrued expense	52.46%7.6M	13.44%2.39M	54.80%-1.69M	403.78%4.27M	-72.75%909K	912.89%4.98M	139.75%2.11M	-35.44%-3.73M	-71.52%847K	51.84%3.34M
-Change in other current assets	-689.86%-545K	-1,507.27%-1.55M	20.00%-88K	-536.36%-70K	-100.23%-1K	---69K	--110K	---110K	---11K	--440K
-Change in other current liabilities	13.74%-408K	-909.80%-515K	-13.09%-501K	-348.46%-1.45M	-13.55%-486K	-6.05%-473K	-128.49%-51K	-219.41%-443K	67.60%-324K	-465.81%-428K
-Change in other working capital	98.47%-3K	97.92%-5K	125.84%77K	77.16%-715K	101.52%19K	60.80%-196K	-47.24%-240K	75.55%-298K	78.74%-3.13M	-454.55%-1.25M
Cash from discontinued investing activities
Operating cash flow	-2,409.91%-29.39M	-37.06%-30.24M	-4.24%-29.09M	12.57%-75.79M	-10.97%-24.65M	94.43%-1.17M	-10.86%-22.07M	-18.50%-27.91M	-25.39%-86.69M	-1.73%-22.21M
Investing cash flow
Cash flow from continuing investing activities	-8.94%27.3M	-249.20%-73.54M	-710.38%-263.26M	778.69%115.72M	81.32%-6.68M	95.05%29.98M	-14.23%49.29M	179.71%43.13M	90.13%-17.05M	-10.80%-35.78M
Net PPE purchase and sale	-339.01%-1.78M	56.65%-349K	29.84%-710K	75.98%-2.77M	49.77%-549K	79.38%-405K	61.04%-805K	84.22%-1.01M	-26.63%-11.54M	78.55%-1.09M
Net investment purchase and sale	-4.30%29.08M	-246.11%-73.19M	-694.78%-262.55M	2,248.86%118.49M	82.32%-6.13M	75.29%30.39M	-15.86%50.09M	192.55%44.14M	96.63%-5.51M	-27.55%-34.69M
Cash from discontinued investing activities
Investing cash flow	-8.94%27.3M	-249.20%-73.54M	-710.38%-263.26M	778.69%115.72M	81.32%-6.68M	95.05%29.98M	-14.23%49.29M	179.71%43.13M	90.13%-17.05M	-10.80%-35.78M
Financing cash flow
Cash flow from continuing financing activities	-94.62%568K	-86.78%17.25M	2,800.05%318.83M	4,983.70%156.83M	132.75%4.76M	2,195.00%10.56M	261,138.00%130.52M	1,647.85%10.99M	-97.39%3.09M	-98.24%2.05M
Net common stock issuance	-99.99%1K	-87.90%15.69M	3,172.72%315.72M	--148.34M	--1K	--8.98M	--129.72M	--9.65M	--0	--0
Proceeds from stock option exercised by employees	-45.48%567K	22.50%1.56M	119.84%3.11M	138.90%8.49M	89.38%4.76M	940.00%1.04M	1,885.94%1.27M	61.83%1.42M	-6.33%3.55M	180.27%2.51M
Net other financing activities	----	----	----	----	----	----	-314.04%-472K	71.95%-69K	---468K	----
Cash from discontinued financing activities
Financing cash flow	-94.62%568K	-86.78%17.25M	2,800.05%318.83M	4,983.70%156.83M	132.75%4.76M	2,195.00%10.56M	261,138.00%130.52M	1,647.85%10.99M	-97.39%3.09M	-98.24%2.05M
Net cash flow
Beginning cash position	-19.99%189.06M	250.77%275.59M	375.84%249.11M	-65.78%52.35M	154.56%275.68M	108.23%236.31M	3.42%78.57M	-65.78%52.35M	-44.71%153M	19.02%108.3M
Current changes in cash	-103.87%-1.52M	-154.86%-86.53M	1.02%26.49M	295.49%196.76M	52.51%-26.57M	859.10%39.37M	320.49%157.74M	134.04%26.22M	18.65%-100.65M	-190.22%-55.95M
End cash Position	-31.97%187.54M	-19.99%189.06M	250.77%275.59M	375.84%249.11M	375.84%249.11M	154.56%275.68M	108.23%236.31M	3.42%78.57M	-65.78%52.35M	-65.78%52.35M
Free cash flow	-1,877.73%-31.17M	-33.76%-30.59M	-3.04%-29.8M	20.01%-78.56M	-8.12%-25.2M	93.14%-1.58M	-4.10%-22.87M	3.49%-28.92M	-25.53%-98.22M	13.46%-23.31M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion with Explanatory Notes	--

Heat List

Overall

No Data